• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Insulin Market Forecast to 2015 Product Image

Insulin Market Forecast to 2015

  • Published: June 2012
  • Region: Global
  • 42 Pages
  • RNCOS E-Services Private Limited

FEATURED COMPANIES

  • Eli Lilly & Company
  • Novo Nordisk
  • Sanofi-Aventis
  • MORE

In the global biopharmaceutical industry, protein-based therapies are effectively being used to treat metabolic disorders, and autoimmune diseases. According to our new research report, the global market for insulin products is progressing on the strong growth trajectory as the number of people suffering from diabetes is increasing at a rapid rate worldwide. It is estimated that the market will advance at a CAGR of around 10% during 2012-2015.

The report, “Insulin Market Forecast to 2015”, says that new innovations in delivery devices are also likely to fuel growth in the global insulin market. In the recent years, many alternatives to insulin syringes have been launched, including pen devices, and insulin pumps. Our comprehensive research work also studies how government initiatives are stimulating the growth, and what are the challenges that the overall market may face in near future.

Our extensive study looks into the competitive landscape and finds that Novo Nordisk is the top player in the global insulin market, followed by Sanofi-Aventis and Eli Lilly. The report includes an overview of the activities of these companies. It also studies key geographies, READ MORE >

1. Analyst View

2. Research Methodology

3. Global Protein Therapeutics Market
3.1 Protein Therapeutics Market Vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2015
3.2.1 Market Segmentation

4. Insulin Market Forecast to 2015
4.1 Scientific Insight
4.2 Current and Future Market Analysis to 2015
4.3 By Application
4.4 Key Geographical Markets
4.5 Key Players and Drugs
4.6 Recent Developments

5. Key Players
5.1 Sanofi-Aventis
5.2 Novo Nordisk
5.3 Eli Lilly & Company

List of Tables

Table 4-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2011 & 2030
Table 4-2: China - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-3: US - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-4: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-5: Japan - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-6: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 5-1: Sanofi-Aventis - Key Products in Protein Therapeutics
Table 5-2: Novo Nordisk - Key Products in Protein Therapeutics
Table 5-3: Eli Lilly - Key Products in Protein Therapeutics

List of Charts

Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2011
Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2011-2015
Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2011
Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2015
Figure 4-1: Global - Insulin Market (Billion US$), 2011-2015
Figure 4-2: Global - Number of Diabetic Patients (Million), 2011 & 2030
Figure 4-3: India - Insulin Market (Million US$), 2011-2015
Figure 4-4: China - Insulin Market (Billion US$), 2011-2015
Figure 4-5: US - Insulin Market (Billion US$), 2011-2015
Figure 4-6: Russia - Insulin Market (Million US$), 2011-2015
Figure 4-7: Japan - Insulin Market (Billion US$), 2011-2015
Figure 4-8: Brazil - Insulin Market (Million US$), 2011-2015
Figure 4-9: Global - Share of Key Players in Insulin Market (2011)
Figure 4-10: Global - Share of Products in Insulin Market (2011)

- Sanofi-Aventis
- Novo Nordisk
- Eli Lilly & Company

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos